Holen Sie sich die Stockscreener-App
97.50
0.84%
0.81
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Abbott Laboratories Aktie (ABT) Neueste Nachrichten
Abbott settled a government infant formula lawsuit for nearly $385 million. - Claim Depot
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.
In 1935, An Illinois Secretary Bought 3 Shares Of Her Company's Stock For $180. She Never Sold A Single Share And Always Reinvested Dividends. By The Time She Died In 2010 Her 3 Abbott Shares Had Turned Into $7.2 Million. - 247wallst.com
Abbott Laboratories’ Quarterly Earnings Preview: What You Need to Know - Barchart.com
Abbott rolls out SimpleScreen CRC blood test across the US - Medical Device Network
Abbott launches SimpleScreen CRC for Abbott Laboratories stock - AD HOC NEWS
Abbott Laboratories stock pre-market at EUR 87.30: plus 0.29 percent - AD HOC NEWS
DOJ Announces $385 Million Settlement to Resolve False Claims Allegations over Abbott Laboratories Baby Formula - MedLearn Publishing
CG Abbott plant included in $385M federal settlement - PinalCentral.com
Abbott (ABT) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
Abbott (ABT) Stock May Be 25% Stretched After Biosensor Market Forecast - Simply Wall Street
Abbott Laboratories stock underperforms Wednesday when compared to competitors - MarketWatch
Abbott Labs launches blood test to screen for colorectal cancer - Kenosha News
Mississippi receives $771K in Abbott formula settlement - wjtv.com
AG Fitch Announces False Claims Settlement with Abbott Laboratories - MageeNews.com
Mississippi to receive more than $771K in $384 million Abbott Laboratories settlement - Darkhorse Press
Abbott Laboratories (ABT) Launches SimpleScreen CRC As Fair Value Stays In Focus - Yahoo! Finance Canada
Mississippi to Receive $771K in $384M False Claims Settlement with Abbott Laboratories - tippahnews.com
Abbott Launches Simplescreen Crc Blood Test in the U.S - marketscreener.com
Abbott launches Freenome’s colorectal cancer screening test - MedTech Dive
In 1935, Grace Groner, a secretary, invested $180 in her employer Abbott; 75 years later, it had grown to - The Economic Times
Abbott Laboratories (NYSE:ABT): Are Investors Getting Over Their Scepticism Over The Company's Bold US$21bn Bet On Exact Sciences? - Stocks Down Under
Form 4 Abbott Laboratories For: 29 September By Investing.com - Investing.com UK
Abbott Laboratories stock at USD 100.95 on September 28, 2026 - AD HOC NEWS
Abbott lawsuit alleges spinal cord stimulators can fail, worsen nerve damage - Top Class Actions
Global Therapeutic Drug Monitoring Consumables Market Forecast, 2026-2032 - GlobeNewswire Inc.
Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward? - Yahoo Finance
Abbott Laboratories Lobbying Profile, 2003 - OpenSecrets
3 Dividend Stocks To Watch As High Rates Test Defensive Shares - Simply Wall Street
Form 4 Abbott Laboratories For: 25 September By Investing.com - Investing.com India
At $103.99 a share, an Abbott Laboratories (ABT) director delivered or withheld shares for exercise costs or taxes. - Stock Titan
Abbott Laboratories stock falls 2.32 percent below yearly high effects? no - AD HOC NEWS
Is Abbott Laboratories (NYSE:ABT) Facing a Real Market Test? - Kalkine Media
Abbott Laboratories stock loses 1.82 percent before the bell - ad-hoc-news.de
How Lingo Partnership Will Impact Abbott Stock (ABT) - Simply Wall Street
Abbott to pay nearly $385 million to settle infant formula allegations - ConsumerAffairs
Abbott Laboratories (ABT) is Facing Segment Competition and Sluggish Nutrition Recovery - Yahoo Finance
Abbott Laboratories stock reports Q2 growth and earnings beat - AD HOC NEWS
Abbott Laboratories stock rises 0.69 percent ahead of the open - AD HOC NEWS
Abbott partners with Berry Street to add nutrition coaching to Lingo - Drug Delivery Business
Abbott Laboratories stock ends the day 0.69 percent higher at USD 103.69 - AD HOC NEWS
Abbott Laboratories: A Strong Business At A Fair Price (NYSE:ABT) - Seeking Alpha
Sinocare Asks Court To Rule Device Won't Infringe Abbott IP - Law360
What Makes Abbott Laboratories (ABT) an Attractive Opportunity? - Yahoo Finance
Abbott and Berry Street team up on personalized nutrition tracking - marketscreener.com
Is Abbott Laboratories (ABT) Still Undervalued On Volt’s First US And Canada Procedures? - Simply Wall Street
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Abbott and Berry Street partner to combine gluc... - Pluang
A 15% discount on Abbott's four-week glucose-monitor plans will go to Berry Street users. - Stock Titan
Abbott Laboratories stock gains 1.12 percent as settlement weighs - AD HOC NEWS
Abbott Laboratories stock heads into the open after a 1.12 percent gain - AD HOC NEWS
The Premium On Abbott Laboratories Keeps Growing. So Does The Case For Stryker and Boston Scientific - Trefis
Calls to sign infant formula testing bill into law in New York - Spectrum News
Abbott Laboratories stock ends the day 1.12 percent higher - AD HOC NEWS
Abbott to pay almost $385M in DOJ settlement over infant formula plant allegations - Compliance Week
Abbott: Quality Remains, But Exact Sciences Has Raised The Bar For Buy (NYSE:ABT) - Seeking Alpha
Sibionics Challenges Abbott Patent In Glucose Monitor Fight - Law360
3 Health Care Stocks With Whale Alerts In Today’s Session - benzinga.com
Abbott Laboratories stock gains 0.36 percent as revenue reaches USD 12.6 billion - AD HOC NEWS
Abbott Laboratories stock heads into the open after a 0.7 percent gain - AD HOC NEWS
Abbott vs. Intuitive Surgical: Two Healthcare Titans on Diverging Growth Curves - NAI500
Abbott Laboratories Agencies, 2018 - OpenSecrets
NC gets $216K from Abbott baby formula settlement - WSOC TV
0.07%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):